blink_lab's profile picture. Digital Sensory Phenotyping for Autism and ADHD

BlinkLab

@blink_lab

Digital Sensory Phenotyping for Autism and ADHD

BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics for neurodevelopmental conditions, is pleased to provide its activity report for the quarter ended September 30 2025, along with a financial and corporate update for the period.…


BlinkLab (ASX: BB1) has completed a US pilot study evaluating the smartphone-based Dx 1 diagnostic device for the assessment of behavioural and developmental concerns in children, including autism spectrum disorder and attention deficit hyperactivity disorder. Read more:…

blink_lab's tweet image. BlinkLab (ASX: BB1) has completed a US pilot study evaluating the smartphone-based Dx 1 diagnostic device for the assessment of behavioural and developmental concerns in children, including autism spectrum disorder and attention deficit hyperactivity disorder.

Read more:…

BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to provide a recording from the recent Investor Webinar where Dr Henk-Jan Boele (BlinkLab’s Co-Founder and CEO) and Mr Brian Leedman (BlinkLab’s Chairman) provided an…

blink_lab's tweet image. BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to provide a recording from the recent Investor Webinar where Dr Henk-Jan Boele (BlinkLab’s Co-Founder and CEO) and Mr Brian Leedman (BlinkLab’s Chairman) provided an…

BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce the successful completion of its United States pilot study evaluating the Company’s smartphone-based digital diagnostic test autism spectrum disorder,…


Yesterday, BlinkLab (ASX:BB1) Chairman, Mr Brian Leedman, presented at Stocks On Location: On Track among a range of leaders from exciting ASX-listed companies across healthcare, finance, and resources. Mr Leedman provided an overview of BlinkLab’s smartphone-based diagnostic…

blink_lab's tweet image. Yesterday, BlinkLab (ASX:BB1) Chairman, Mr Brian Leedman, presented at Stocks On Location: On Track among a range of leaders from exciting ASX-listed companies across healthcare, finance, and resources.

Mr Leedman provided an overview of BlinkLab’s smartphone-based diagnostic…

Mr Brian Leedman, Chairman of BlinkLab Limited (ASX:BB1), featured today as a speaker at Stocks On Location: On Track – hosted by the incredible team at The Capital Network and partnered with Foley Durham Executive Search & Board Advisory. As BlinkLab advances its AI-powered…

blink_lab's tweet image. Mr Brian Leedman, Chairman of BlinkLab Limited (ASX:BB1), featured today as a speaker at Stocks On Location: On Track – hosted by the incredible team at The Capital Network and partnered with Foley Durham Executive Search & Board Advisory.

As BlinkLab advances its AI-powered…

BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce that it has engaged The Vanderbilt Kennedy Center (VKC) in Nashville, Tennessee as the latest clinical research site for its ongoing FDA 510(k) diagnostic…


BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce it has engaged The University of Missouri Thompson Center for Autism & Neurodevelopment to serve as a clinical research site as part of its ongoing FDA…


BlinkLab Limited (ASX:BB1), a digital healthcare company developing AI-powered diagnostic tools, today announced that Cincinnati Children’s Medical Center and Seattle Children’s Research Institute have been engaged as additional clinical sites for the main study phase of its…


BlinkLab Limited (ASX:BB1) is pleased to provide a recording from the recent TechKnow Invest Roadshow, where Chairman Brian Leedman highlighted the company's latest activities. 📺 Watch video: buff.ly/Y6nayN $BB1 #awareness #autismspeaks

blink_lab's tweet image. BlinkLab Limited (ASX:BB1) is pleased to provide a recording from the recent TechKnow Invest Roadshow, where Chairman Brian Leedman highlighted the company's latest activities.

📺 Watch video: buff.ly/Y6nayN

$BB1 #awareness #autismspeaks

BlinkLab Limited (ASX:BB1), a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce it has engaged The University of Pennsylvania Perelman School of Medicine as its third clinical site for its ongoing FDA 510(k) diagnostic trial for the…


BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU

blink_lab's tweet image. BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow.  

Register via buff.ly/xZ0EptZ 

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.  

$BB1 #awareness #autismspeaks @VEvents_RIU

BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Download the latest Investor presentation: buff.ly/QZ8wk11 Please email [email protected] to arrange a 1:1 meeting. $BB1.ax #awareness

blink_lab's tweet image. BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow.

Download the latest Investor presentation: buff.ly/QZ8wk11

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.

$BB1.ax #awareness…

🔊 REMINDER: Brian Leedman presenting TODAY!

BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU

blink_lab's tweet image. BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow.

Register via buff.ly/xZ0EptZ

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.

$BB1 #awareness #autismspeaks @VEvents_RIU


Blinklab is pleased to be included in the recent @StockheadAU article "Morgans spotlights nine healthcare stocks with upcoming catalysts" Read more: buff.ly/Gf4FZa4 $BB1 #awareness #autismspeaks


BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow. Register via buff.ly/xZ0EptZ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks @VEvents_RIU

blink_lab's tweet image. BlinkLab Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the TechKnow Invest Roadshow.

Register via buff.ly/xZ0EptZ

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.

$BB1 #awareness #autismspeaks @VEvents_RIU

🔊 REMINDER: BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, presenting TODAY!

BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit. Register via buff.ly/JTn1xJ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks

blink_lab's tweet image. BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit.

Register via buff.ly/JTn1xJ

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.

$BB1  #awareness #autismspeaks


BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit. Register via buff.ly/JTn1xJ Please email [email protected] to arrange a 1:1 meeting. $BB1 #awareness #autismspeaks

blink_lab's tweet image. BlinkLab Limited (ASX:BB1) Non-Executive Chairman, Brian Leedman, is pleased to be presenting at the 19th Bioshares Biotech Summit.

Register via buff.ly/JTn1xJ

Please email info@janemorganmanagement.com.au to arrange a 1:1 meeting.

$BB1  #awareness #autismspeaks

BlinkLab (ASX:BB1) is pleased to provide shareholders and investors with its activities report to accompany the Appendix 5B for the quarter ending 30 June 2025. Read more: buff.ly/thHQDY7 $BB1 #awareness #autismspeaks


United States Trends

Loading...

Something went wrong.


Something went wrong.